Categories AlphaGraphs, Earnings, Health Care
ANGO Earnings: Highlights of AngioDynamics’ Q3 2024 results
AngioDynamics Inc. (NASDAQ: ANGO) has reported a wider net loss for the third quarter of 2024 when the medical device maker’s revenue declined. The company also issued guidance for fiscal 2024.
Net loss, excluding special items, was $0.16 per share in the February quarter, compared to a loss of $0.03 per share in the corresponding period of 2023. On an unadjusted basis, net loss was $190.4 million or $4.73 per share in Q3, vs. a loss of $9.5 million or $0.24 per share in the prior-year quarter.
Third-quarter revenues decreased 7% year-over-year to $75.2 million. The company expects fiscal 2024 revenues to be in the range of $270 million to $275 million.
Commenting on the results, AngioDynamics’ CEO Jim Clemmer said, “Subsequent to the end of our fiscal third quarter, we reached a settlement agreement with BD/Bard that provides us with clarity and certainty going forward. This allows us to avoid continued litigation and keep the team focused on further developing our key growth platforms.”
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
After a weak first half, will NIKE (NKE) hit the recovery path this year?
After a prolonged slowdown, NIKE, Inc. (NYSE: NKE) is working on a turnaround plan to regain the brand’s strength. In recent years, the sneaker giant’s overall performance has not been
Important takeaways from Paychex’s (PAYX) Q2 2025 earnings report
Paychex Inc. (NASDAQ: PAYX), a leading provider of human resources and payroll services, reported better-than-expected revenue and profit for the second quarter of fiscal 2025, sending the stock higher soon
Lamb Weston’s (LW) challenges may not end soon, a few points to note
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) turned red in mid-day trade on Friday. The stock has dropped 19% in the past one month. The company delivered disappointing results
